Baker Sheikh, Abu and Perisetti, Abhilash and Javed, Nismat and Shekhar, Rahul (2020) Eribulin and Confusion: A Previously Unknown Drug Side-Effect. European Journal of Case Reports in Internal Medicine, 7 (9). pp. 1-3. ISSN ISSN: 2284-2594
|
Text
1708-Article Text-14080-1-10-20200608.pdf - Published Version Download (216kB) | Preview |
Abstract
Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Eribulin, encephalopathy, breast cancer |
| Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Marina Spanti |
| Date Deposited: | 15 Dec 2021 12:38 |
| Last Modified: | 15 Dec 2021 12:38 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/20986 |
Actions (login required)
 |
View Item |
